News
Webinar: Key success criteria for hearing preclinical trials – Replay
You can watch the replay of our webinar conducted with ENT Clinical on November 12th 2020 about "Key success criteria for hearing preclinical trials". If you would like to learn more about the preclinical models discussed in this webinar, please contact Dr Wahid Awad...
The Auditory Impact of Covid-19
CILcare Opens a New Subsidiary In Denmark
Montpellier, November 09th 2020 – CILcare, a world leading CRO entirely dedicated to ear disorders, announces today the opening of a new subsidiary in Copenhagen, Denmark. Already established in the US, the French company is joining the Medicon Valley Alliance, a...
Webinar Nov 12: key success criteria for hearing (pre)clinical trials
In collaboration with ENT Clinical, we present the webinar: Key success criteria for hearing (pre)clinical trials November 12, 2020 - 18:00 CET We are pleased to announce that this webinar, which is host by Dr. Helen Blackshaw, will be presented by: Prof. Anne...
CILcare-CBSET nominated for the prestigious PRIX Galien Medstartup award
CILcare-CBSET nominated for the prestigious PRIX Galien Medstartup award in the ‘Best Collaboration Dedicated to the Developing or Underserved Populations Worldwide’ Category Montpellier, France — September 30, 2020 — CILcare, a leading CRO specializing in...
CILcare enhances its regulatory expertise with Marie-Pierre Pasdelou’s appointment as Chief Regulatory Officer
Montpellier, September 3rd, 2020: CILcare, world leading CRO specialized in the field of hearing, announced today that Dr. Marie-Pierre PASDELOU, CILcare’s co-founder and current Chief Development Officer, is taking over CILcare’s Regulatory Affairs and Quality...
HEAR THIS! Potential Therapeutics for COVID-19 Should Be Tested for Auditory Safety
Issued in World Pharma Today, August 24, 2020 As the COVID-19 pandemic continues to spread across the world, clinicians, academic institutions, private organizations, and governments are working tirelessly to find treatments to help patients and at-risk populations...
